istars - iSTARS

Inteligência Artificial em Saúde em 2026: o que é possível e o que será necessário para lá chegar

Inteligência Artificial em Saúde em 2026: o que é possível e o que será necessário para lá chegar

By istars|2026-02-09T10:06:27+00:00February 9th, 2026|

Os sistemas de saúde estão cada vez mais sob pressão, desde a escassez de profissionais até aos tempos de espera mais longos e ao excesso de carga administrativa. Neste contexto, a Inteligência Artificial surge como uma ferramenta prática para apoiar os profissionais, melhorar os cuidados aos doentes e ajudar os sistemas a gerir a crescente procura. Em 2026, o foco já não é se a IA vai transformar a saúde, mas como poderá fazê-lo à escala.

Health AI in 2026: Exploring What’s Possible and What It Will Take to Get There

Health AI in 2026: Exploring What’s Possible and What It Will Take to Get There

By istars|2026-02-09T10:06:11+00:00February 9th, 2026|

Healthcare systems are under growing strain, from staff shortages to longer waiting times and administrative overload. In this context, Artificial Intelligence is emerging as a practical tool to support professionals, improve patient care, and help systems manage rising demand. In 2026, the focus is no longer if AI will shape healthcare, but how it can do so at scale.

REDCap Platform Launched at FMUL with Support from iSTARS

REDCap Platform Launched at FMUL with Support from iSTARS

By istars|2026-01-21T12:25:18+00:00January 21st, 2026|

The iSTARS project is pleased to support the launch of REDCap at the Lisbon School of Medicine, making a widely used research data management platform available to the FMUL research community.

Ontogenetic Diversification of Type 2 Conventional Dendritic Cells in the Bone Marrow: A Central Logic for Peripheral Immunity

By istars|2026-01-13T10:57:14+00:00January 13th, 2026|

Baber, R. W., Magalhães-Patrício, M. Â., Pires, M. V., Correia, V., Lozano-Gil, J. M., Guimarães, J. C., Brown, C. C., Dalod, M., & Minutti, C. M. [...]

Luis Serrano

Luis Serrano

By istars|2025-11-11T10:34:43+00:00November 11th, 2025|

Advisor

Francisca Leite

Francisca Leite

By istars|2025-11-03T11:37:39+00:00November 3rd, 2025|

Advisor

Ana Teresa Freitas

Ana Teresa Freitas

By istars|2025-11-03T11:42:37+00:00November 3rd, 2025|

Advisor

Ana Godinho

Ana Godinho

By istars|2025-11-03T11:25:30+00:00November 3rd, 2025|

Advisor

Inês Carvalho

Inês Carvalho

By istars|2025-11-07T11:52:46+00:00October 18th, 2025|

iSTARS Data Scientist

iSTARS ERA Chair João Guimarães Contributes to Study on the Effects of Low-Dose Radiation on Metastasis

iSTARS ERA Chair João Guimarães Contributes to Study on the Effects of Low-Dose Radiation on Metastasis

By istars|2025-09-16T08:42:22+00:00September 16th, 2025|

A new study published in the International Journal of Molecular Sciences has investigated how low doses of ionizing radiation, that can affect tissues and organs near a tumour during cancer treatment, may influence the formation of pre-metastatic niches in the lungs. This process involves changes in the lung tissue that make it more receptive to disseminated breast cancer cells settling and growing there later on – forming metastasis.

About istars